Jagsonpal Pharmaceuticals Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.9%1-day move

₹200.50

prior close

₹200.50

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.6+2.5+2.2+2.8-0.9+1.6+3.7+4.0+3.9+4.7+2.7+3.1+14.7+9.4

Up moveDown movePending

AI summary

Jagsonpal Pharmaceuticals Limited has notified exchanges about a scheduled earnings conference call for Tuesday, April 28, 2026, at 3:00 PM IST to discuss its Q4 FY26 financial results. The call is being hosted by Go India Advisors, and retail investors can join via dial-in numbers provided. Key company participants include CFO Nirav Vora, MD Manish Gupta, and COO Amrut Medhekar. This is a routine investor engagement activity filed under SEBI Regulation 30. No financial figures or forward-looking statements were disclosed in this filing.

Likely market impact

This is a standard regulatory disclosure with no immediate share price impact. The call may provide early cues on Q4 FY26 performance when the CFO and MD speak, which market participants typically track ahead of the formal results announcement.